Skip to main content

Estabrook Capital Management

Position in GILD — Gilead Sciences, Inc.

CIK 1344717 NEW YORK, NY

Position in GILD

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$151,608
-$17,865 QoQ
Shares Held
1,200
-1.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,949
of 2,266 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Estabrook Capital Management holds $58,767,979 across 13 Drug Manufacturers - General names. GILD ranks #9 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in GILD

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $151,608 1,200
2026-03-31 $169,473 1,216
2025-12-31 $147,288 1,200
2025-09-30 $133,200 1,200
2025-06-30 $133,044 1,200
2025-03-31 $134,460 1,200
2024-12-31 $110,844 1,200
2024-09-30 $100,608 1,200
2024-06-30 $82,332 1,200
2024-03-31 $87,900 1,200
2023-12-31 $97,212 1,200
2023-09-30 $89,928 1,200
2023-06-30 $92,484 1,200
2023-03-31 $99,564 1,200
2022-12-31 $103,020 1,200
2022-09-30 $74,028 1,200
2022-06-30 $74,172 1,200
2022-03-31 $71,340 1,200
2021-12-31 $87,132 1,200